Preoperative immunotherapy for resectable hepatocellular carcinoma: Toward a paradigm shift?

J Hepatol. 2020 Dec;73(6):1588-1590. doi: 10.1016/j.jhep.2020.05.048. Epub 2020 Sep 17.
No abstract available

Keywords: Complete pathologic response; Immunotherapy; Neoadjuvant; PD-L1 inhibitor; Resectable hepatocellular carcinoma.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / immunology
  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / surgery
  • Female
  • Hepatectomy* / adverse effects
  • Hepatectomy* / methods
  • Humans
  • Immune Checkpoint Inhibitors / administration & dosage
  • Immunohistochemistry
  • Immunotherapy / methods
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / immunology
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / surgery
  • Liver* / diagnostic imaging
  • Liver* / pathology
  • Neoadjuvant Therapy / methods*
  • Perioperative Period
  • Preoperative Care / methods
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immune Checkpoint Inhibitors
  • avelumab